These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 15367190)
1. Plasma TGF-beta1 as a risk factor for gingival overgrowth. Ellis JS; Morgan CL; Kirby JA; Taylor JJ; Thomason JM J Clin Periodontol; 2004 Oct; 31(10):863-8. PubMed ID: 15367190 [TBL] [Abstract][Full Text] [Related]
2. Prevalence of gingival overgrowth in transplant patients immunosuppressed with tacrolimus. Ellis JS; Seymour RA; Taylor JJ; Thomason JM J Clin Periodontol; 2004 Feb; 31(2):126-31. PubMed ID: 15016038 [TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-beta1 gene expression and cyclosporine A-induced gingival overgrowth: a pilot study. Radwan-Oczko M; Boratyńska M; Zietek M; Dobosz T J Clin Periodontol; 2008 May; 35(5):371-8. PubMed ID: 18355347 [TBL] [Abstract][Full Text] [Related]
4. The influence of transforming growth factor-beta1 gene polymorphisms on the severity of gingival overgrowth associated with concomitant use of cyclosporin A and a calcium channel blocker. Linden GJ; Haworth SE; Maxwell AP; Poulton KV; Dyer PA; Middleton D; Irwin CR; Marley JJ; McNamee P; Short CD; Hull PS; James JA J Periodontol; 2001 Jun; 72(6):808-14. PubMed ID: 11453244 [TBL] [Abstract][Full Text] [Related]
6. The relationship of transforming growth factor-beta1 gene polymorphism, its plasma level, and gingival overgrowth in renal transplant recipients receiving different immunosuppressive regimens. Radwan-Oczko M; Boratyńska M; Zietek M; Zołedziewska M; Jonkisz A J Periodontol; 2006 May; 77(5):865-73. PubMed ID: 16671880 [TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of marginal parodontium condition in patients after kidney graft treated with calcineurine inhibitors and calcium channel blockers. Radwan-Oczko M; Boratynska M; Zietek M Bull Group Int Rech Sci Stomatol Odontol; 2004; 46(2-3):46-51. PubMed ID: 16335621 [TBL] [Abstract][Full Text] [Related]
8. Oral health status, oral microflora, and non-surgical periodontal treatment of renal transplant patients receiving cyclosporin A and FK506. Chu FC; Tsang PC; Chan AW; Leung WK; Samaranayake LP; Chan TM Ann R Australas Coll Dent Surg; 2000 Oct; 15():286-91. PubMed ID: 11709958 [TBL] [Abstract][Full Text] [Related]
10. Effect of adjunctive roxithromycin therapy on interleukin-1β, transforming growth factor-β1 and vascular endothelial growth factor in gingival crevicular fluid of cyclosporine A-treated patients with gingival overgrowth. Gong Y; Lu J; Ding X; Yu Y J Periodontal Res; 2014 Aug; 49(4):448-57. PubMed ID: 23947915 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of transforming growth factor-beta 1 level in crevicular fluid of cyclosporin A-treated patients. Buduneli N; Kütükçüler N; Aksu G; Atilla G J Periodontol; 2001 Apr; 72(4):526-31. PubMed ID: 11338306 [TBL] [Abstract][Full Text] [Related]
12. TGF-β1 gene polymorphism in renal transplant patients with and without gingival overgrowth. Kozak M; Kurzawski M; Wajda A; Lapczuk J; Lipski M; Dziewanowski K; Drozdzik M Oral Dis; 2011 May; 17(4):414-9. PubMed ID: 21306480 [TBL] [Abstract][Full Text] [Related]
13. Cyclosporin but not tacrolimus significantly increases salivary cytokine contents in rats. Spolidorio LC; Holzhausen M; Spolidorio DM; Nassar CA; Nassar PO; Muscará MN J Periodontol; 2005 Sep; 76(9):1520-5. PubMed ID: 16171442 [TBL] [Abstract][Full Text] [Related]
14. Atorvastatin treatment in the short term: does it induce renoprotection or vasculoprotection in renal transplantation? Navarro-Muñoz M; Bonet J; Bayés B; Lauzurica R; Blanco S; Romero R Transplant Proc; 2007 Sep; 39(7):2259-63. PubMed ID: 17889157 [TBL] [Abstract][Full Text] [Related]